| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |